Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities

被引:19
作者
Ghoran, Salar Hafez [1 ]
El-Shazly, Mohamed [2 ]
Sekeroglu, Nazim [3 ]
Kijjoa, Anake [4 ,5 ]
机构
[1] Golestan Univ, Fac Sci, Dept Chem, Gorgan 1575949138, Golestan, Iran
[2] German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmaceut Biol, Cairo 11835, Egypt
[3] Kilis 7 Aralik Univ, Fac Agr, Dept Hort, TR-79000 Kilis, Turkey
[4] ICBAS Inst Ciencias Biomed Abel Salazar, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal
[5] CIIMAR, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal
关键词
COVID-19; SARS-CoV; phytochemicals; medicinal plants; ACE2; enzyme inhibitors; HERPES-SIMPLEX-VIRUS; SARS-COV 3CL(PRO); ANTIVIRAL ACTIVITIES; INHIBITION; PROTEASE; GLYCYRRHIZIN; DERIVATIVES; REPLICATION; INFECTIONS; FLAVONOIDS;
D O I
10.3390/molecules26061754
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since the emergence of severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2) first reported in Wuhan, China in December 2019, COVID-19 has spread to all the continents at an unprecedented pace. This pandemic has caused not only hundreds of thousands of mortalities but also a huge economic setback throughout the world. Therefore, the scientific communities around the world have focused on finding antiviral therapeutic agents to either fight or halt the spread of SARS-CoV-2. Since certain medicinal plants and herbal formulae have proved to be effective in treatment of similar viral infections such as those caused by SARS and Ebola, scientists have paid more attention to natural products for effective treatment of this devastating pandemic. This review summarizes studies and ethnobotanical information on plants and their constituents used for treatment of infections caused by viruses related to the coronavirus family. Herein, we provide a critical analysis of previous reports and how to exploit published data for the discovery of novel therapeutic leads to fight against COVID-19.
引用
收藏
页数:28
相关论文
共 65 条
[1]   INVITRO ANTIVIRAL ACTIVITY OF A SAPONIN FROM ANAGALLIS-ARVENSIS, PRIMULACEAE, AGAINST HERPES-SIMPLEX VIRUS AND POLIOVIRUS [J].
AMOROS, M ;
FAUCONNIER, B ;
GIRRE, RL .
ANTIVIRAL RESEARCH, 1987, 8 (01) :13-25
[2]  
[Anonymous], 2005, Pharmacopoeia of the Peoples Republic of China (version 2005, V1
[3]   ANTIVIRAL ACTIVITY OF GLYCYRRHIZIN AGAINST VARICELLA-ZOSTER VIRUS INVITRO [J].
BABA, M ;
SHIGETA, S .
ANTIVIRAL RESEARCH, 1987, 7 (02) :99-107
[4]   Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits [J].
Bellavite, Paolo ;
Donzelli, Alberto .
ANTIOXIDANTS, 2020, 9 (08) :1-18
[5]   Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections [J].
Bonam, Srinivasa Reddy ;
Kotla, Niranjan G. ;
Bohara, Raghvendra A. ;
Rochev, Yury ;
Webster, Thomas J. ;
Bayry, Jagadeesh .
NANO TODAY, 2021, 36
[6]   Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients [J].
Bonam, Srinivasa Reddy ;
Kaveri, Srini, V ;
Sakuntabhai, Anavaj ;
Gilardin, Laurent ;
Bayry, Jagadeesh .
CELL REPORTS MEDICINE, 2020, 1 (02)
[7]  
Chang FR, 2012, NAT PROD COMMUN, V7, P1415
[8]   Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication [J].
Chen, Chung-Jen ;
Michaelis, Martin ;
Hsu, Hseng-Kuang ;
Tsai, Chin-Chuan ;
Yang, Kunder D. ;
Wu, Yang-Chang ;
Cinatl, Jindrich, Jr. ;
Doerr, Hans Wilhelm .
JOURNAL OF ETHNOPHARMACOLOGY, 2008, 120 (01) :108-111
[9]   Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3′- digallate (TF3) [J].
Chen, CN ;
Lin, CPC ;
Huang, KK ;
Chen, WC ;
Hsieh, HP ;
Liang, PH ;
Hsu, JTA .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2005, 2 (02) :209-215
[10]   In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds [J].
Chen, F ;
Chan, KH ;
Jiang, Y ;
Kao, RYT ;
Lu, HT ;
Fan, KW ;
Cheng, VCC ;
Tsui, WHW ;
Hung, IFN ;
Lee, TSW ;
Guan, Y ;
Peiris, JSM ;
Yuen, KY .
JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (01) :69-75